Skip to main content

Advertisement

SpringerLink
Log in

Increased number of Epstein-Barr virus latently infected B-cells in T-cell non-Hodgkin's lymphoma tissues

  • Original Papers
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

Epstein-Barr virus (EBV) is a causative agent of malignant lymphomas occurring in immunocompromised hosts. Similar lymphoid tumors can be induced in mice with severe combined immunodeficiency (SCID mice) by transplanting human B-cells with latently infected EBV. We have previously observed that when apparently EBV-negative lymphomas were engrafted into SCID mice, 11 of 18 T-cell non-Hodgkin's lymphomas (NHLs) produced EBV associated lymphomas, but only 2 of 30 engrafted with B-NHLs. Previous studies suggested that EBV-infected cell inducing lymphomas in SCID mice may preferentially exist in T-cell NHL tissues. To prove this assumption, in situ hybridization (ISH) using oligonucleotide probes for EBV-encoded small RNAs 1 (EBER1) was used in this study to demonstrate EBV-bearing lymphocytes in NHL tissues. It was found that EBV-bearing cells existe in 9 of the 10 T-cell NHL surgical specimens. By contrast, in B cell NHLs, only 2 of 10 carried EBV-bearing cells. Further semi-quantitative analysis demonstrated that apparently significantly more EBV-bearing cells were present in T-cell NHL tissues than in B-cell NHLs. Moreover, these EBV-bearing cells in lymphoma tissues were shown to be of B-cell lineage, by the combinated analysis of immunostaining with CD20 and ISH with EBER1. These results indicated the increase of EBV-bearing B-cells in T-cell NHL tissues, suggesting the activation of B-cells with latently infected EBV by neoplastic T-cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301: 527–530

    Google Scholar 

  2. Cen H, Williams PA, McWilliams HP, Breing MC, Ho OO, McKnight JL (1983) Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders. Blood 81: 1393–1403

    Google Scholar 

  3. Chen CL, Sadler RH, Walling DM, Su IJ, Hsieh HC, Raab-Traub N (1993) Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol 67: 6303–6308

    Google Scholar 

  4. Fukayama M, Ibuki T, Hayashi Y (1993) Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am J Pathol 143: 1044

    Google Scholar 

  5. Gaffey MJ, Weiss LM (1992) Association of Epstein-Barr virus with human neoplasia. Pathol Ann 27: 55–74

    Google Scholar 

  6. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T (1990) Epstein-Barr virus in nasal T-cell lymphomas in patient with iethal middline granuloma. Lancet 335: 128–130

    Google Scholar 

  7. Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Muller-Lantzsch N, Stein H (1991) Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 88: 4766–4770

    Google Scholar 

  8. Hironaka T, Nagasaki M, Morikawa S, Hirai K (1993) Detection of Epstein-Barr virus transcripts in chemically or immunologically-activated cells and in a null cell-line (HLN-STL-C) by in situ hybridization with alkaline phosphatase-linked oligonucleotide probes. J Virol Metch 44: 141–154

    Google Scholar 

  9. Howe JG, Steitz JA (1986) Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci USA 83: 9006–9010

    Google Scholar 

  10. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (RAP) Procedures. J Histochem Cytochem 29: 577–580

    Google Scholar 

  11. Ibuta T, Fukayama M, Hayashi Y, Funata N, Koike M, Ikeda T, Mizutani S (1994) Pyothoraxassociated pleural lymphoma. A case evolving from T-cell rich lymphoid infiltration to overt B-cell lymphoma in association with Epstein-Barr virus. Cancer 73: 738–744

    Google Scholar 

  12. Ioth T, Shiota M, Takanashi M, Hojo I, Satoh H, Matsuzawa A, Moriyama T, Watanabe T, Hirai K, Mori S (1993) Engraftment of human malignant lymphomas in severe combined immunodeficiency (SCID) mice. Cancer 72: 2686–2694

    Google Scholar 

  13. Kawa-Ha K, Ishihara S, Ninomiya T, Yumara-Yagi K, Hara J, Murayama F, Tawa A, Hirai K (1989) CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 84: 51

    Google Scholar 

  14. Masucci MG, Gavioli R, de Campos-Lima PO (1993) Transformation-associated Epstein-Barr virus antigens as targets for immune attack. Ann NY Acad Sci 690: 86

    Google Scholar 

  15. Mosier DE, Gulized RJ, Baird SM, Wilson DB (1988) Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335: 256–259

    Google Scholar 

  16. Nadal D, Albini B, Schlapfer E, Berbstein JM, Ogra PL (1992) Role of Epstein-Barr virus and interleukin 6 in the development of lymphomas of human origin in SCID mice engrafted with human tonsillar mononuclear cells. J Gen Virol 73: 113–121

    Google Scholar 

  17. Rickinson AB, Wallace LE, Epstein MA (1980) HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells. Nature 283: 865–967

    Google Scholar 

  18. Sasajima Y, Yamabe H, Kobashi Y, Hirai K, Mori S (1993) High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas. Am J Pathol 143: 1280–1285

    Google Scholar 

  19. Shibata D, Weiss LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM (1993) Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 81: 2102–2109

    Google Scholar 

  20. Veronese ML, Veronesi A, D'Andrea E, Del Mistro A, Indraccolo S, Mazza MR, Minon M, Zamarchi R, Menin C, Panozzo M, Amadori A, Chieco-Bianchi L (1992) Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation. J Exp Med 176: 1763–1767

    Google Scholar 

  21. Weiss LM, Movahed LA, Warnke RA, Sklar J (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320: 502–506

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

    I. Hojo, M. Takanashi & S. Mori

  2. Department of Cell Regulation, Division of Virology and Immunology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan

    I. Hojo, M. Takanashi & K. Hirai

Authors
  1. I. Hojo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Takanashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Hirai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hojo, I., Takanashi, M., Hirai, K. et al. Increased number of Epstein-Barr virus latently infected B-cells in T-cell non-Hodgkin's lymphoma tissues. Archives of Virology 140, 1419–1426 (1995). https://doi.org/10.1007/BF01322668

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01322668

Keywords

Search

Navigation